Enwei Pharmaceutical Co., Ltd. (301331.SZ)

21.87 -0.16 (-0.73%) At close: 03:04PM CST

Enwei Pharmaceutical Co., Ltd.

No. 458, Shuanghua Road
Section 3 Shuangliu District
Chengdu 610200
China
86 28 8154 8888
https://www.enwei.com.cn

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 1,552

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Yongjiang Xue	Chairman & CEO	N/A	N/A	1971
Mr. Xue Gang	Vice Chairman & President	N/A	N/A	1973
Ms. Aiqun Zhou	Board Secretary & VP	N/A	N/A	1960
Mr. Lei Chen	Vice President	N/A	N/A	1976
Mr. Dawei Hu	Financial Director	N/A	N/A	1987
Mr. Zhuang Yan	VP & Director	270.6k	N/A	1961

Amounts are as of 31 December 2019, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Enwei Pharmaceutical Co., Ltd. develops and sells Chinese medicines in China. It offers drugs in the areas of gynecology, pediatrics, respiratory system, and other pharmaceutical fields. The company was founded in 2005 and is based in Chengdu, China.

Corporate governance

Enwei Pharmaceutical Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.